David B. Weiner, Director at INOVIO PHARMACEUTICALS, INC. (INO), sold 7,000 shares at $9.18 ($66K) on 2021-03-08, disclosed to the SEC on 2021-03-09.
Scheduled sale ($66k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.18 | 3,500 | $32K | 48.9% |
| 2 | $9.60 | 3,500 | $34K | 51.1% |
| Total | $9.39 avg | 7,000 | $66K | 100% |
| Filing → |
| INO | SELL | 2022-08-11 | $32K | — | Filing → |
| INO | SELL | 2022-05-17 | $18K | — | Filing → |
| INO | SELL | 2022-03-14 | $13K | — | Filing → |